On clinical manifestations of the new coronavirus infection in newborns.

The aim of the research. To study the specifics in manifestations of the new coronavirus infection in newborns. Material and methods. A retrospective analysis of observations of 28 newborns diagnosed with the new coronavirus infection SARS-CoV-2 dated from June to December 2020 was performed. The infants were transferred from the perinatal centre for hospitalisation to the infectious department of a children's hospital. The patients were born to mothers with COVID-19 as well as mothers discharged from hospital and hospitalised later due to COVID-19 acquired through family contact. Clinical and laboratory data of 12 female and 16 male children aged 1 to 28 days were studied. Results. Clinical symptoms of the new coronavirus infection in newborns tend to be different: from asymptomatic course in 46.5 % of the patients to evident pneumonia in 50 % of the children. The newborns admitted with COVID-19 acquired through family contact had more severe disease manifestations. Conclusion. Amidst the pandemic rise of its incidence, the new coronavirus infection COVID-19 is not rare among newborns. COVID-19 newborns did not have a registered severe nosocomial infection, sepsis, multisystem inflammatory syndrome.Copyright © 2022, Krasnoyarsk State Medical University. All rights reserved.

Marked variability in institutional deliveries and neonatal outcomes during the COVID-19 lockdown in Nigeria.

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic and the interventions to mitigate its spread impacted access to healthcare, including hospital births and newborn care. This study evaluated the impact of COVID-19 lockdown measures on newborn service utilization in Nigeria. METHODS: The records of women who delivered in hospitals and babies admitted to neonatal wards were retrospectively reviewed before (March 2019-February 2020) and during (March 2020-February 2021) the COVID-19 pandemic lockdown in selected facilities in Nigeria. RESULTS: There was a nationwide reduction in institutional deliveries during the COVID-19 lockdown period in Nigeria, with 14 444 before and 11 723 during the lockdown-a decrease of 18.8%. The number of preterm admissions decreased during the lockdown period (30.6% during lockdown vs 32.6% pre-lockdown), but the percentage of outborn preterm admissions remained unchanged. Newborn admissions varied between zones with no consistent pattern. Although neonatal jaundice and prematurity remained the most common reasons for admission, severe perinatal asphyxia increased by nearly 50%. Neonatal mortality was significantly higher during the COVID-19 lockdown compared with pre-lockdown (110.6/1000 [11.1%] vs 91.4/1000 [9.1%], respectively; p=0.01). The odds of a newborn dying were about four times higher if delivered outside the facility during the lockdown (p<0.001). CONCLUSIONS: The COVID-19 lockdown had markedly deleterious effects on healthcare seeking for deliveries and neonatal care that varied between zones with no consistent pattern.

Features of Lymphocyte Subset Composition in Neonates Born to Mothers Suffered from Covid-19 at Different Stages of Pregnancy

The relationship between the incidence of COVID-19 in pregnant women who have had a coronavirus infection at different gestational ages and the health status of paired neonates is of great interest. However, no sufficient convincing data fully reflecting features of subsequent neonatal period, the state of the immune system in this category of children, affecting characteristics of postnatal period have been accumulated. Based on this, it underlies the relevance of the current study aimed at investigating parameters of clinical and immunological state of neonatal health after paired mothers recovered from COVID-19 at different gestational ages. The prospective study included 131 women and 132 children. The main group consisted of women (n = 61) who had COVID-19 during pregnancy and paired newborns (n = 62) at gestational age (GA) of 37-41 weeks, the comparison group - women without laboratory-confirmed COVID-19 during pregnancy (n = 70) and paired newborns (n = 70) of similar gestational age. While analyzing the anamnesis of the patients, no significant differences in somatic and obstetric-gynecological diseases were found. Analyzing course of pregnancy revealed that low molecular weight heparins were significantly more often applied in the main group. The term and frequency of delivery by caesarean section in pregnant women in the main group did not significant differ from that of the control group. No significant difference in the frequency of causes accounting for the severity of the condition of neonates in paired mothers with COVID-19 at different trimester of gestation was found. Investigating lymphocyte subset composition, neutrophil phagocytic activity, and IgG class antibodies specific to SARS-CoV-2 was carried out. It was found that lymphocyte subset profile in newborns from paired mothers with COVID-19 at different trimesters of gestation differed only in the level of NK cells (CD56+) in children born to mothers recovered from COVID-19 in the first trimester. In this study, in general, no severe perinatal outcomes in newborns from paired mothers with COVID-19 during pregnancy were documented. No cases of moderate or severe maternal COVID-19 were observed. Therefore, further prospective studies are needed to assess an impact of COVID-19 severity on maternal and fetal birth outcomes and clarify optimal management of pregnant women in such cases.

A new coronavirus infection in pregnant women: risks for the mother and the newborn

A review of the literature is devoted to the information on the effect of a new coronavirus infection (COVID-19) on the course of pregnancy, the possibility of vertical transmission of the virus from mother to fetus and the condition of the neonates. A review of the literature reveals similarities in the clinical manifestations of COVID-19 in pregnant and non-pregnant women. However, pregnant women are reported to have an increased risk of ICU admission and need for ventilatory support in various countries. Trans-placental transmission from the mother to the fetus has been widely reported. Preterm birth is now common among pregnancy outcomes, especially in women who have had moderate to severe COVID-19. In the assessment of newborns born to mothers with COVID-19, prematurity, hypoxic conditions and respiratory disorders predominated. Further study of the pathogenesis of a new coronavirus infection is necessary to determine factors of possible vertical transmission, the effect on fetal growth and development, the course of pregnancy and labor, and peculiarities of the early neonatal period in infants whose mothers had had this infection in the first and second trimesters of pregnancy. © 2023, Media Sphera Publishing Group. All rights reserved.

SARS-CoV-2 VIRAL LOAD IN NEWBORNS WITH COVID-19

The article presents the results of investigation of SARS-CoV-2 viral load in newborns with RT-PCR confirmed COVID-19 of different severity. It has been revealed that total amount of SARS-CoV-2 RNA on nasopharyngeal mucosa of newborns is significantly higher as compared to elder children and is not associated with disease severity and lung injury.

FEATURES OF LYMPHOCYTE SUBSET COMPOSITION IN NEONATES BORN TO MOTHERS SUFFERED FROM COVID-19 AT DIFFERENT STAGES OF PREGNANCY.

The relationship between the incidence of COVID-19 in pregnant women who have had a coronavirus infection at different gestational ages and the health status of paired neonates is of great interest. However, no sufficient convincing data fully reflecting features of subsequent neonatal period, the state of the immune system in this category of children, affecting characteristics of postnatal period have been accumulated. Based on this, it underlies the relevance of the current study aimed at investigating parameters of clinical and immunological state of neonatal health after paired mothers recovered from COVID-19 at different gestational ages. The prospective study included 131 women and 132 children. The main group consisted of women (n = 61) who had COVID-19 during pregnancy and paired newborns (n = 62) at gestational age (GA) of 37-41 weeks, the comparison group - women without laboratory-confirmed COVID-19 during pregnancy (n = 70) and paired newborns (n = 70) of similar gestational age. While analyzing the anamnesis of the patients, no significant differences in somatic and obstetric-gynecological diseases were found. Analyzing course of pregnancy revealed that low molecular weight heparins were significantly more often applied in the main group. The term and frequency of delivery by caesarean section in pregnant women in the main group did not significant differ from that of the control group. No significant difference in the frequency of causes accounting for the severity of the condition of neonates in paired mothers with COVID-19 at different trimester of gestation was found. Investigating lymphocyte subset composition, neutrophil phagocytic activity, and IgG class antibodies specific to SARS-CoV-2 was carried out. It was found that lymphocyte subset profile in newborns from paired mothers with COVID-19 at different trimesters of gestation differed only in the level of NK cells (CD56+) in children born to mothers recovered from COVID-19 in the first trimester. In this study, in general, no severe perinatal outcomes in newborns from paired mothers with COVID-19 during pregnancy were documented. No cases of moderate or severe maternal COVID-19 were observed. Therefore, further prospective studies are needed to assess an impact of COVID-19 severity on maternal and fetal birth outcomes and clarify optimal management of pregnant women in such cases.Copyright © 2023 Saint Petersburg Pasteur Institute. All rights reserved.

Recommendations for the Diagnosis and Treatment of Maternal SARS-CoV-2 Infection

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread worldwide and threatened human's health. With the passing of time, the epidemiology of coronavirus disease 2019 evolves and the knowledge of SARS-CoV-2 infection accumulates. To further improve the scientific and standardized diagnosis and treatment of maternal SARS-CoV-2 infection in China, the Chinese Society of Perinatal Medicine of Chinese Medical Association commissioned leading experts to develop the Recommendations for the Diagnosis and Treatment of Maternal SARS-CoV-2 Infection under the guidance of the Maternal and Child Health Department of the National Health Commission. This recommendations includes the epidemiology, diagnosis, management, maternal care, medication treatment, care of birth and newborns, and psychological support associated with maternal SARS-CoV-2 infection. It is hoped that the recommendations will effectively help the clinical management of maternal SARS-CoV-2 infection.Copyright © Wolters Kluwer Health, Inc. All rights reserved.

Evaluation of clinical manifestations of coronavirus delta variant in neonates admitted to a hospital in northern Iran during the sixth wave: A case series.

Eleven newborns infected with COVID-19 delta variant admitted to a hospital in northern Iran during the sixth wave were evaluated. Fever, poor breastfeeding, lethargy, and lung involvement were the most prevalent symptoms in COVID-19 delta variant infected neonates. Infected mothers may be a main cause of infection for neonates.

An update on vaccination in preterm infants.

OBJECTIVE: The objective of this article is to review the most current literature on vaccines, focusing on their safety, immunogenicity, and efficacy in preterm newborns, aiming to improve vaccine coverage in this population. DATA SOURCE: Most recent scientific publications addressing the immunization of preterm newborns. DATA SYNTHESIS: Despite its immunological immaturity, vaccination is well tolerated by preterm infants, and protective immune responses are observed, but some studies have shown that preterm infants undergo unjustified delays in their vaccination schedule. CONCLUSIONS: Despite being widely recommended, the routine immunization of preterm infants is often delayed, putting this vulnerable population at risk for several diseases, many of which are preventable by immunization. Every effort should be made to develop universal guidelines that define the immunization of preterm infants.

The course of COVID-19 in newborns.

Clinical Infectious Diseases Hospital. S.P. Botkin has been providing assistance to pregnant women and newborns suffering from COVID-19 since the beginning of the pandemic. In the period from April 2020 to April 2022, 550 newborns born to mothers suffering from COVID-19 of varying severity were observed in the hospital, of which 52 children had a registered diagnosis of COVID-19 (the SARS-CoV-2 virus was identified in a swab from the nasopharynx of a newborn using PCR). In this paper, an analysis of the pathological changes identified in this category of newborns was carried out, the issues of the influence of the covid status of the mother and the duration of stay with her on the child's condition were studied. Analysis of the results of the work revealed a relationship between the duration of the period of stay of a newborn with a mother with an active form of COVID-19 and the severity of the disease in newborns. According to our clinical observations, the vertical route of transmission of the virus seems highly probable. Newborns who have had COVID-19 or have perinatal contact with SARS-CoV-2 are subject to dynamic observation. It is necessary to determine the order, timing and scope of dispensary observation for the timely detection of pathological changes in this category of children.Copyright © 2022 Authors. All rights reserved.

The course of COVID-19 in newborns.

Clinical Infectious Diseases Hospital. S.P. Botkin has been providing assistance to pregnant women and newborns suffering from COVID-19 since the beginning of the pandemic. In the period from April 2020 to April 2022, 550 newborns born to mothers suffering from COVID-19 of varying severity were observed in the hospital, of which 52 children had a registered diagnosis of COVID-19 (the SARS-CoV-2 virus was identified in a swab from the nasopharynx of a newborn using PCR). In this paper, an analysis of the pathological changes identified in this category of newborns was carried out, the issues of the influence of the covid status of the mother and the duration of stay with her on the child's condition were studied. Analysis of the results of the work revealed a relationship between the duration of the period of stay of a newborn with a mother with an active form of COVID-19 and the severity of the disease in newborns. According to our clinical observations, the vertical route of transmission of the virus seems highly probable. Newborns who have had COVID-19 or have perinatal contact with SARS-CoV-2 are subject to dynamic observation. It is necessary to determine the order, timing and scope of dispensary observation for the timely detection of pathological changes in this category of children.Copyright © 2022 Authors. All rights reserved.

The course of COVID-19 in newborns

Clinical Infectious Diseases Hospital. S.P. Botkin has been providing assistance to pregnant women and newborns suffering from COVID-19 since the beginning of the pandemic. In the period from April 2020 to April 2022, 550 newborns born to mothers suffering from COVID-19 of varying severity were observed in the hospital, of which 52 children had a registered diagnosis of COVID-19 (the SARS-CoV-2 virus was identified in a swab from the nasopharynx of a newborn using PCR). In this paper, an analysis of the pathological changes identified in this category of newborns was carried out, the issues of the influence of the covid status of the mother and the duration of stay with her on the child's condition were studied. Analysis of the results of the work revealed a relationship between the duration of the period of stay of a newborn with a mother with an active form of COVID-19 and the severity of the disease in newborns. According to our clinical observations, the vertical route of transmission of the virus seems highly probable. Newborns who have had COVID-19 or have perinatal contact with SARS-CoV-2 are subject to dynamic observation. It is necessary to determine the order, timing and scope of dispensary observation for the timely detection of pathological changes in this category of children. © 2022 Authors. All rights reserved.

The course of COVID-19 in newborns

Clinical Infectious Diseases Hospital. S.P. Botkin has been providing assistance to pregnant women and newborns suffering from COVID-19 since the beginning of the pandemic. In the period from April 2020 to April 2022, 550 newborns born to mothers suffering from COVID-19 of varying severity were observed in the hospital, of which 52 children had a registered diagnosis of COVID-19 (the SARS-CoV-2 virus was identified in a swab from the nasopharynx of a newborn using PCR). In this paper, an analysis of the pathological changes identified in this category of newborns was carried out, the issues of the influence of the covid status of the mother and the duration of stay with her on the child's condition were studied. Analysis of the results of the work revealed a relationship between the duration of the period of stay of a newborn with a mother with an active form of COVID-19 and the severity of the disease in newborns. According to our clinical observations, the vertical route of transmission of the virus seems highly probable. Newborns who have had COVID-19 or have perinatal contact with SARS-CoV-2 are subject to dynamic observation. It is necessary to determine the order, timing and scope of dispensary observation for the timely detection of pathological changes in this category of children. © 2022 Authors. All rights reserved.

The Outbreak of Coronavirus Disease 2019 (COVID-19) and its Manifestation

The outbreak of coronavirus disease 2019 (COVID-19) was first reported in Wuhan, Chi-na, and soon the infection turned into a pandemic. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the spread of COVID-19 infection. The World Health Organization (WHO) confirmed 4.20% of total deaths globally (March 21, 2020). Within four months (July 21, 2020), the rate of confirmed total deaths was recorded up to 4.17% globally. In India, 909 confirmed cases and 19 deaths were reported by Health and Family Welfare, Government of India, on March 28, 2020. Over a period of 123 days in India, 1638870 confirmed cases and 35684 deaths were reported. COVID-19 can potentially spread from person to person through direct contact or respiratory droplets from coughing and sneezing. The most common symptoms are fever, dry cough, difficulty in breathing, and fatigue. A pregnant mother with COVID-19 has fewer chances of trans-ferring this infection to her newborn baby. Children are less affected than adults from this virus. A specific antiviral drug or vaccine has not been developed to cure the disease to date. Drugs including chloroquine, hydroxychloroquine, lopinavir, ritonavir, nafamostat, nitazoxanide, and remde-sivir, have been observed to be effective for treating COVID-19. Many vaccine candidates are under investigation in pre-clinical and clinical studies. In this review, we highlight the epidemiology, signs and symptoms, pathogenesis, and mode of transmission of the infection caused by COVID-19, and its effects on a pregnant mother and newborn, and children. We also highlight the preventive measures and drugs that are effective for treating COVID-19.Copyright © 2021 Bentham Science Publishers.

Risk of COVID-19 in newborns depending on the infection course in the mother.

The incidence of the new coronavirus infection (COVID-19) remains a global problem worldwide. However, the effect of COVID-19 on the course of pregnancy and the possibility of intrauterine infection are insufficiently investigated. Recent studies suggest the possibility of a transplacental transmission of infection caused by SARS-CoV-2. Goal: To analyze SARS-Cov-2 RNA detection cases in newborns and to study possible factors influencing the infection of newborns from mothers with COVID-19. Materials and methods. From March to August 2020, there were 64 births to women with a confirmed diagnosis of COVID-19 at the Botkin's Infection Disease Hospital. In 15 newborns, the diagnosis of COVID-19 was laboratory confirmed. In this study, the histories of 14 newborns and their mothers were analyzed retrospectively. The diagnosis of COVID-19 was based on the detection of SARS-Cov-2 RNA in a nasopharyngeal swab or in fecal samples. Results. Analysis of the histories of mothers showed that 4 (28.6%) patients had an asymptomatic disease. Three (21.4%) women had a severe course of COVID-19, 7 (50%) patients had a course of moderate severity. Fetal hypoxia was more common in women with severe or moderate course of COVID-19. In 6 (42.7%) newborns, a positive nasopharyngeal swab was obtained within 48 hours after birth. None of the women whose children were RNA-positive in the first two days had a severe form of the disease, and two patients had an asymptomatic disease. Conclusion. 1. The frequency of detection of SARS-CoV-2 RNA in newborns from mothers with COVID-19 (under mother-child separation) was 21.9%. 2. Infection of a newborn with SARS-CoV-2 is possible both with a severe course of the disease in the mother and with an asymptomatic course. 3. A caesarean section does not exclude the possibility of a newborn infection with SARS-CoV-2. 4. In newborns, in most cases, an asymptomatic course of COVID-19 is observed.Copyright © 2022 Interregional public organization Association of infectious disease specialists of Saint-Petersburg and Leningrad region (IPO AIDSSPbR). All rights reserved.

Risk of COVID-19 in newborns depending on the infection course in the mother.

The incidence of the new coronavirus infection (COVID-19) remains a global problem worldwide. However, the effect of COVID-19 on the course of pregnancy and the possibility of intrauterine infection are insufficiently investigated. Recent studies suggest the possibility of a transplacental transmission of infection caused by SARS-CoV-2. Goal: To analyze SARS-Cov-2 RNA detection cases in newborns and to study possible factors influencing the infection of newborns from mothers with COVID-19. Materials and methods. From March to August 2020, there were 64 births to women with a confirmed diagnosis of COVID-19 at the Botkin's Infection Disease Hospital. In 15 newborns, the diagnosis of COVID-19 was laboratory confirmed. In this study, the histories of 14 newborns and their mothers were analyzed retrospectively. The diagnosis of COVID-19 was based on the detection of SARS-Cov-2 RNA in a nasopharyngeal swab or in fecal samples. Results. Analysis of the histories of mothers showed that 4 (28.6%) patients had an asymptomatic disease. Three (21.4%) women had a severe course of COVID-19, 7 (50%) patients had a course of moderate severity. Fetal hypoxia was more common in women with severe or moderate course of COVID-19. In 6 (42.7%) newborns, a positive nasopharyngeal swab was obtained within 48 hours after birth. None of the women whose children were RNA-positive in the first two days had a severe form of the disease, and two patients had an asymptomatic disease. Conclusion. 1. The frequency of detection of SARS-CoV-2 RNA in newborns from mothers with COVID-19 (under mother-child separation) was 21.9%. 2. Infection of a newborn with SARS-CoV-2 is possible both with a severe course of the disease in the mother and with an asymptomatic course. 3. A caesarean section does not exclude the possibility of a newborn infection with SARS-CoV-2. 4. In newborns, in most cases, an asymptomatic course of COVID-19 is observed.Copyright © 2022 Interregional public organization Association of infectious disease specialists of Saint-Petersburg and Leningrad region (IPO AIDSSPbR). All rights reserved.

PREGNANCY AND PERINATAL OUTCOMES OF COVID-19 (SARS-COV-2).

This article presents current data on the impact of COVID-19 (SARS-CoV-2) on pregnancy and perinatal consequences. The working theories of the pathogenesis of obstetric and fetal complications due to infection during pregnancy, already proven to date, are considered. Symptoms of COVID-19 disease, the risk of their development, and frequency of severe disease in non-pregnant and pregnant women of reproductive age do not differ significantly. However, there are powerful studies that have shown that this infection in pregnant women leads to a high probability of a dramatically severe and fulminant course. Pregnant women with SARS-CoV-2 infection have an increased risk of preeclampsia, incl. severe, hemolysis, thrombocytopenia and increased levels of liver enzymes compared with pregnant women without infection. Women who have COVID-19 are twice as likely to have preterm rupture of the membranes and three times as likely to have a preterm birth compared to the not infected pregnant women. Vertical transmission of the virus from mother to fetus is likely, but data are insufficient to be certain. There is also insufficient evidence of an increased miscarriage rate and teratogenic effects of the COVID-19 virus. However, antenatal fetal death is statistically significantly more common in infected pregnant women than in uninfected pregnant women. Morphological and functional disorders in the chorion/placenta are the main pathogenetic factor in the development of preeclampsia, intrauterine growth retardation, antenatal fetal death and impaired state of the fetus and children born by women with COVID-19. Many studies report that mothers with confirmed COVID-19 infection has asymptomatic babies. At the same time, some studies indicate adverse complications in newborns from infected mothers. The most common neonatal disorders in babies from pregnant women with COVID-19 are tachypnea, hyperthermia, and gastrointestinal disorders, in particular vomiting and flatulence. Further research of the COVID-19 impact on pregnancy and perinatal outcomes is urgently needed.Copyright © 2022 Trylyst. All rights reserved.

Pro-and Antioxidant Status in Newborn with COVID-19.

There is practically no information on the state of oxidative stress reactions in newborns with coronavirus infections. At the same time, such studies are extremely important and can contribute to better understanding of the process of reactivity in patients of different ages. The content of pro- and antioxidant status indicators was assessed in 44 newborns with confirmed COVID-19. It was found that the content of compounds with unsaturated double bonds, primary, secondary, and final LPO products were elevated in newborns with COVID-19. These changes were accompanied by higher SOD activity and retinol level and reduced activity of glutathione peroxidase. Contrary to popular opinion, newborns can be a COVID-19-susceptible age group and require more close monitoring of metabolic reactions during the period of neonatal adaptation that is an aggravating background during infection.

Consequences of SARS-CoV-2 Infection in Pregnant Women and Their Infants: A Systematic Review.

Coronavirus disease 2019 (COVID-19) is a worldwide health problem, particularly for pregnant women. This review assesses the effects of COVID-19 on pregnant women and their infants. A systematic search was performed of studies published on PubMed, Web of Science, Google Scholar, and Embase from January 2020 to January 2021, without restriction by language. This review included 27 studies (22 from China, one from the United States, one from Honduras, one from Italy, one from Iran, and one from Spain), which cumulatively evaluated 386 pregnant women with clinically confirmed COVID-19 and their 334 newborns. Of the 386 pregnant women, 356 had already delivered their infants, four had medical abortions at the time of research, 28 were still pregnant, and two died from COVID-19 before they were able to give birth. Cesarean sections were performed on 71% of pregnant women with COVID-19 to give birth. Fever and cough were common symptoms among women. Premature rupture of membranes, distress, and preterm birth were pregnancy complications. Low birth weight and a short gestational age were common outcomes for newborns. The common laboratory findings among pregnant women were lymphopenia, leukocytosis, and elevated levels of C-reactive protein. Chest computed tomography revealed abnormal viral lung changes in 73.3% of women. Eleven infants tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There was no evidence of vertical transmission. Most infants were observed to have lymphopenia and thrombocytopenia. The clinical features of pregnant women were found to be similar to those of generally infected patients. There is evidence of adverse pregnancy and neonatal outcomes caused by COVID-19.

IMPACT OF THE NOVEL CORONAVIRUS INFECTION (COVID-19) EXPERIENCED BY PREGNANT WOMEN ON THE HEALTH OF NEWBORNS

Background: Due to the high spread rate of SARS-CoV-2 and to the rapid increase in its incidence, including those among pregnant women, the novel coronavirus infection (COVID-19) has become a challenge in modern healthcare. Objective(s): To analyze the impact of the novel coronavirus infection experienced by pregnant women on the health of newborns in the early neonatal period. Material(s) and Method(s): A retrospective analysis was carried out of the birth records of 400 women who had experienced the novel coronavirus infection during pregnancy and the neonatal records of their newborns (n=500) who received health care in the clinical units of the V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia (Center), in July 2020 to July 2021. A comparison group consisted of randomly selected birth records of 495 pregnant women who had not been infected with COVID-19 and the neonatal records of their babies (n=500) born at the same Center at the same time. Result(s): The vast majority of women who had been infected with COVID-19 during pregnancy were found to have familial obstetric/gynecological and/or somatic histories. Among the factors aggravating pregnancy in the presence of COVID-19, chronic hypertension, hereditary thrombophilia, fat metabolism disorders, urogenital infections, and anemia are more common than those in the control group (p<0.05). This female group also tended to have miscarriage;however, no statistically significant differences could be detected (p=0.06). There were no statistically significant differences in the term and frequency of cesarean delivery in pregnant women in the study and control groups (p>0.05). Neonates born to women who had been infected with COVID-19 in the first trimester had its statistically significantly higher morbidity rates (p<0.05). The frequency of perinatal complications was higher in newborns whose mothers had experienced the novel coronavirus infection in the first trimester. Neonatal infants borns from women who had a new coronavirus infection in the third trimester, rhinitis and otitis media are statistically significantly more common in the early neonatal period. Among the factors leading to disruption of early neonatal adaptation of children whose mothers had a new coronavirus infection during pregnancy, the following were statistically significantly more common: infectious and inflammatory diseases (rhinitis, otitis media), hemorrhagic syndrome, and hypoglycemia (p<0.05). Neonates born to women who had been infected with COVID-19 in the first trimester were observed to have statistically significantly higher morbidity rates (p<0.05). The incidence of perinatal complications was higher in newborns whose mothers had experienced the novel coronavirus infection in the first trimester. Neonatal infants born to women who had the novel coronavirus infection in the third trimester were statistically significantly more commonly recorded to have rhinitis and otitis media in the early neonatal period. Among the factors leading to failure of early neonatal adaptation of babies whose mothers had the novel coronavirus infection during pregnancy, there were statistically significantly more often infectious and inflammatory diseases (rhinitis, otitis media), hemorrhagic syndrome, and hypoglycemia (p<0.05). Conclusion(s): The incidence of perinatal complications in babies born to women who had been infected with COVID-19 depended on their gestational age and was higher than that in newborns whose mothers had experienced the novel coronavirus infection in the first trimester. At the same time, the incidence of infectious and inflammatory diseases proved to be higher in infants whose mothers had a coronavirus infection in the third trimester. Failure of early neonatal adaptation of babies born to women who had an infection caused by SARS-CoV-2 during pregnancy may be due to both infectious and non-infectious factors that complicate the course of pregnancy and childbirth. Copyright © A group of authors, 2022.